Total Holdings
61
Portfolio diversification across 61 positions
XPH
(NYSEARCA)State Street SPDR S&P Pharmaceuticals ETF
$57.49-- (--)
Loading... - Market loading
XPH ETF Holdings: State Street SPDR S&P Pharmaceuticals ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$299.40M
Total fund assets
Expense Ratio
0.35%
Annual management fee
Fund Issuer
State Street
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Tarsus Pharmaceuticals Inc | Stock | 3.42% |
| 2 |  | Jazz Pharmaceuticals plc | Stock | 3.35% |
| 3 |  | Eli Lilly and Company | Stock | 3.34% |
| 4 |  | Nuvation Bio Inc | Stock | 3.13% |
| 5 |  | Ligand Pharmaceuticals Incorporated | Stock | 2.90% |
| 6 |  | Crinetics Pharmaceuticals Inc | Stock | 2.90% |
| 7 |  | Elanco Animal Health Incorporated | Stock | 2.80% |
| 8 |  | Johnson & Johnson | Stock | 2.79% |
| 9 |  | Axsome Therapeutics, Inc | Stock | 2.79% |
| 10 |  | Avadel Pharmaceuticals plc | Stock | 2.75% |
| 11 |  | Merck & Co., Inc | Stock | 2.73% |
| 12 |  | Royalty Pharma plc | Stock | 2.56% |
| 13 |  | Corcept Therapeutics Incorporated | Stock | 2.53% |
| 14 |  | Liquidia Corporation | Stock | 2.53% |
| 15 | D DFTX | Definium Therapeutics, Inc. | Stock | 2.47% |
| 16 |  | Innoviva, Inc | Stock | 2.45% |
| 17 |  | Terns Pharmaceuticals Inc | Stock | 2.45% |
| 18 |  | Harmony Biosciences Holdings Inc | Stock | 2.43% |
| 19 |  | Viatris Inc | Stock | 2.40% |
| 20 |  | Pfizer Inc | Stock | 2.40% |
| 21 |  | Bristol-Myers Squibb Company | Stock | 2.35% |
| 22 |  | MBX Biosciences, Inc. | Stock | 2.35% |
| 23 |  | Supernus Pharmaceuticals, Inc | Stock | 2.34% |
| 24 |  | Amneal Pharmaceuticals, Inc. | Stock | 2.27% |
| 25 |  | Prestige Consumer Healthcare Inc | Stock | 2.20% |
| 26 |  | Phibro Animal Health Corporation | Stock | 2.19% |
| 27 |  | Ocular Therapeutix Inc | Stock | 2.17% |
| 28 |  | Edgewise Therapeutics, Inc. | Stock | 2.15% |
| 29 |  | Organon & Co. | Stock | 2.12% |
| 30 |  | Zoetis Inc. | Stock | 2.02% |
| 31 |  | Perrigo Company plc | Stock | 1.98% |
| 32 |  | ANI Pharmaceuticals, Inc | Stock | 1.95% |
| 33 |  | Harrow Health Inc | Stock | 1.92% |
| 34 |  | Enliven Therapeutics, Inc. | Stock | 1.91% |
| 35 |  | Xeris Biopharma Holdings, Inc. | Stock | 1.87% |
| 36 |  | Arvinas, Inc | Stock | 1.66% |
| 37 |  | CorMedix Inc | Stock | 1.63% |
| 38 |  | Trevi Therapeutics Inc | Stock | 1.61% |
| 39 |  | Pacira BioSciences, Inc | Stock | 1.60% |
| 40 |  | Collegium Pharmaceutical Inc | Stock | 1.55% |
| 41 |  | Mind Medicine (MindMed) Inc | Stock | 1.54% |
| 42 |  | Amphastar Pharmaceuticals, Inc | Stock | 1.36% |
| 43 |  | Phathom Pharmaceuticals, Inc | Stock | 1.34% |
| 44 |  | Wave Life Sciences Ltd | Stock | 1.25% |
| 45 | K KMPH | KemPharm Inc | Stock | 1.20% |
| 46 |  | LENZ Therapeutics Inc | Stock | 1.02% |
| 47 |  | Eyepoint Pharmaceuticals Inc | Stock | 0.94% |
| 48 |  | Esperion Therapeutics, Inc | Stock | 0.93% |
| 49 |  | Evolus, Inc | Stock | 0.92% |
| 50 |  | Theravance Biopharma Inc | Stock | 0.40% |